Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Article
Nature 449, 564-569 (16 September 2007) | doi:10.1038/nature06116;
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
nature jobs
Business Devlopment Officer
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
3 Postdoctoral positions available
- Baylor College of Medicine
- Houston, Texas, USA
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
&
Abstract
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).

